CD47, enabling the escape of cancer cells from macrophage-mediated phagocytosis [14], CD276 (B7-H3) and CTLA4, two immune checkpoint molecules involved in inhibition of immune response [15,16], were progressively increased (Figure 1). Here, CD276 is linked to cancer.